- Endocrine Technology, L.L.C. is CDC registered Organization for National Diabetes Prevention Program.
- Our Organization Code is 3258196
- We offer intensive life style modification program in Pre Diabetes subjects.
- Our Program is both Onsite and Online
- To learn more about “National Diabetes Prevention Program” visit
- Top most researchers have shown 58% reduction in progression of Pre diabetes to diabetic state.
2. Patients: Prevention of Diabetes Complications
- Endocrine Technology, L.L.C. has retained the services of Board Certified Internists with specialty training in Diabetes.
- They are trained in our technology advances to offer “Medical Consultancy services” to prevent complications of diabetes.
- This program at present is offered onsite where we accept most insurances.
- For the details of Bio of Endocrinologist see the page “About US”
The Scientific Basis of our Program is outlined below.
- The Current Evidenced based therapeutic guidelines for diabetes management is step wise approach and “are based on the principal of treat to failure” leading to considerable inertia causing two years delay in instituting appropriate therapies that can reduce HbA1C levels significantly.
- This accelerates complications of diabetes. Adding to this problem is the insurance guidelines that are based on “Expert’s guidelines of step wise approach”. This delays introduction of effective therapies to lower HbA1C.
- Major technology advances have taken place in the prevention of diabetes and complications. These advances provide multipronged approach, reduce frequency of testing for blood sugar and medications while improving compliance. However, its rapid implementation is poor.
- Our approaches are in keeping with the recent guidelines of (American Associations of College of Endocrinology, AACE) that proposes an accelerated approach for “Evidenced based Guidelines” and its applications where the wait time for failure and change of therapy should not be more than 3 months. (Sullivan M. G.“AACE stresses life style in new approach to Type 2 DM” published in Clinical Endocrinology News, 2016, Feb. Vol11: 2, page 1-3).
3. Healthcare Organization Partnership Program
- The Mission of Endocrine Technology, LLC is to prevent Diabetes and its complications in both USA and India where we have approved patents.
- We work with Major Medical Practices, Hospitals, research organizations as well as university centers to develop innovative solutions (Products and Services) for the prevention of diabetes and its complications.
- Our patented technology advances are supported by over three thousand publications globally http://www.ncbi.nlm.nih.gov/pubmed/?term=Factor+H
- Researchers: Our proprietary products for prevention of diabetes and its complications are offered to researchers to support their objectives to develop novel diabetic therapies to prevent complications of diabetes. www.nanoshel.com is our partner in this.
- Biotechnology Industry: We offer product and consulting services for research and development, testing of novel conjugation products to verify our claims for inhibition of diabetes complications. It will stimulate new research, new patents, collaborations and partnerships.
4. Consulting Services
- CURE OF TYPE DIABETES: CONSULTANCY
- PREVENTION OF TYPE 2 DIABETES
- PREVENTING COMPLICATIONS OF DIABETES
- clinical trial services: NEW CLINICAL TRIAL FOR PREVENTION OF DIABETES AND COMPLICATIONS DIABETES ENROLLME